Combination McL-1 Inhibitors With Anti-Cancer Agents
Copyright © Targeted News Service 2024
2024-04-16
ALEXANDRIA, Virginia, April 16 -- GILEAD SCIENCES, INC., Foster City, California has been assigned a patent (No. US 11957693 B2, initially filed June 9, 2022) developed by three inventors Thomas F. Kenney, Seattle, Washington; Clinton K. Matson, Redmond, Washington; and Chandrasekar Venkataramani, San Carlos, California, for "Combination MCL-1 inhibitors with anti-cancer agents." . . .